THAR
Tharimmune Inc.
NASDAQ: THAR · HEALTHCARE · BIOTECHNOLOGY
$3.23
+3.53% today
Updated 2026-04-30
Market cap
$177.09M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.68
Dividend yield
—
52W range
$1 – $9
Volume
0.6M
Tharimmune Inc. (THAR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-706113.00 | $-1.08M | $-1.09M | $-6.56M | $-7.30M | $-10.90M |
| Capital expenditures | $3.00 | $0.00 | $0.00 | $0.00 | $4.00 | $0.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — |
| Free cash flow | $-706116.00 | $-1.08M | $-1.09M | $-6.56M | $-7.30M | $-10.90M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |